title: PharmGKB summary: isoniazid pathway, pharmacokinetics.
authors.affiliation: Departments of aGenetics bBioengineering, Stanford University, Stanford cKeck School of Medicine of University of Southern California, Los Angeles, California, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Pharmacology, University of Oxford, Oxford, UK.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Klein
authors.forename: Sotiria
authors.initials: S
authors.lastname: Boukouvala
authors.forename: Ellen M
authors.initials: EM
authors.lastname: McDonagh
authors.forename: Scott R
authors.initials: SR
authors.lastname: Shuldiner
authors.forename: Nicola
authors.initials: N
authors.lastname: Laurieri
authors.forename: Caroline F
authors.initials: CF
authors.lastname: Thorn
authors.forename: Russ B
authors.initials: RB
authors.lastname: Altman
authors.forename: Teri E
authors.initials: TE
authors.lastname: Klein
mesh_terms: D006801:Humans; D007538:Isoniazid / Q000737:chemistry* / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity; D010597:Pharmacogenetics; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D007538:Isoniazid